(Q38255902)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273317%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

review article

1 reference

title

Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273317%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273317%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Federica Barutta

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273317%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Serena Grimaldi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273317%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Gabriella Gruden

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273317%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

2 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273317%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273317%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273317%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273317%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

730-742

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273317%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12020-014-0437-1

20 February 2020

exact match

0 references

cites work

Surrogate end points for clinical trials of kidney disease progression

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Diabetic kidney disease with and without albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Clinical significance of nonalbuminuric renal impairment in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Intercellular Adhesion Molecule-1–Deficient Mice Are Resistant Against Renal Injury After Induction of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Macrophages directly mediate diabetic renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Activated macrophages down-regulate podocyte nephrin and podocin expression via stress-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Macrophage diversity in renal injury and repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Tumor necrosis factor receptor cross-talk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Interleukin 1-alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Role of the TNF pathway in the progression of diabetic nephropathy in KK-A(y) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Chemokines, osteopontin, ICAM-1 gene expression in cultured rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

TNF alpha induces expression of the chemoattractant cytokine RANTES in cultured mouse mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Distinct contributions of TNF receptor 1 and 2 to TNF-induced glomerular inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Screening and identification of substances that regulate nephrin gene expression using engineered reporter podocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Transcriptional suppression of nephrin in podocytes by macrophages: roles of inflammatory cytokines and involvement of the PI3K/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Emerging drugs for managing kidney disease in patients with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

NH2-terminal probrain natriuretic peptide is associated with diabetes complications in the EURODIAB Prospective Complications Study: the role of tumor necrosis factor-α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

High ambient glucose augments angiotensin II-induced proinflammatory gene mRNA expression in human mesangial cells: effects of valsartan and simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Effect of retinoic acid in experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Mechanical stretch induces monocyte chemoattractant activity via an NF-kappaB-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells: inhibition by rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

TGF-beta1 stimulates monocyte chemoattractant protein-1 expression in mesangial cells through a phosphodiesterase isoenzyme 4-dependent process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

TGF-beta1 induces IL-8 and MCP-1 through a connective tissue growth factor-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Integrins induce expression of monocyte chemoattractant protein-1 via focal adhesion kinase in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

The MCP-1/CCR2 system has direct proinflammatory effects in human mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

The monocyte chemoattractant protein-1/cognate CC chemokine receptor 2 system affects cell motility in cultured human podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Role for macrophage metalloelastase in glomerular basement membrane damage associated with alport syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

MCP-1/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

The MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

The effects of anti-inflammatory and anti-angiogenic DNA vaccination on diabetic nephropathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Late onset of Ccl2 blockade with the Spiegelmer mNOX-E36-3'PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Serum monocyte chemoattractant protein-1 and monocyte adhesion molecules in type 1 diabetic patients with nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Endocannabinoid-mediated control of synaptic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Endocannabinoids in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Recent advances in the development of selective CB(2) agonists as promising anti-inflammatory agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Cannabinoid receptor 1 mediates high glucose-induced apoptosis via endoplasmic reticulum stress in primary cultured rat mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Cannabinoid receptor 2 expression in human proximal tubule cells is regulated by albumin independent of ERK1/2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Is lipid signaling through cannabinoid 2 receptors part of a protective system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Roles of Rho/ROCK and MLCK in TNF-α-induced changes in endothelial morphology and permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0437-1

The prognostic value of monocyte chemoattractant protein-1/CCL2 in acute coronary syndromes

21 January 2018

1 reference

12 December 2020

TNF-alpha stimulates monocyte adhesion to glomerular mesangial cells. The role of intercellular adhesion molecule-1 gene expression and protein kinases.

1 reference

12 December 2020

Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis.

1 reference

12 December 2020

A novel C-C chemokine receptor 2 antagonist prevents progression of albuminuria and atherosclerosis in mouse models

1 reference

12 December 2020

Interleukin-1 beta and tumor necrosis factor-alpha induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells

1 reference

12 December 2020

Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF-alpha stimulation, and effects of a phosphodiesterase inhibitor

1 reference

12 December 2020

Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats

1 reference

12 December 2020

Involvement of tumor necrosis factor-alpha in the pathogenesis of experimental and human glomerulonephritis.

1 reference

12 December 2020

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

1 reference

12 December 2020

A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells

1 reference

12 December 2020

Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13.

1 reference

12 December 2020

Debate: CON position. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?

1 reference

12 December 2020

Failure to phosphorylate AKT in podocytes from mice with early diabetic nephropathy promotes cell death

1 reference

12 December 2020

Cytotoxic effect of autocrine and macrophage-derived nitric oxide on cultured rat mesangial cells

1 reference

12 December 2020

High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-kappa B-dependent

1 reference

12 December 2020

Activation of mesangial cells with TNF-alpha stimulates M-CSF gene expression and monocyte proliferation: evidence for involvement of protein kinase C and protein tyrosine kinase

1 reference

12 December 2020

Stimulated kidney tubular epithelial cells express membrane associated and secreted TNF alpha

1 reference

12 December 2020

Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy.

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy

1 reference

12 December 2020

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

1 reference

12 December 2020

The endocannabinoid-CB2 receptor axis protects the ischemic heart at the early stage of cardiomyopathy

1 reference

12 December 2020

Effect of pentoxifylline on renal function and urinary albumin excretion in patients with diabetic kidney disease: the PREDIAN trial

1 reference

12 December 2020

Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein

1 reference

12 December 2020

[Influence of high glucose and mannose binding lectin complement pathway activation to IL-6 and TNF-alpha's expression by human renal glomerular endothelial cells].

1 reference

12 December 2020

Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy

1 reference

12 December 2020

Transfused Macrophages Ameliorate Pancreatic and Renal Injury in Murine Diabetes Mellitus

1 reference

12 December 2020

Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy

1 reference

12 December 2020

The role of macrophages in diabetic glomerulosclerosis

1 reference

12 December 2020

Shiga toxin-1 regulation of cytokine production by human glomerular epithelial cells

1 reference

12 December 2020

TNF-alpha induces actin cytoskeleton reorganization in glomerular epithelial cells involving tyrosine phosphorylation of paxillin and focal adhesion kinase

1 reference

12 December 2020

Debate: PRO position. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?

1 reference

12 December 2020

Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells.

1 reference

12 December 2020

Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats

1 reference

12 December 2020

Macrophages promote prosclerotic responses in cultured rat mesangial cells: a mechanism for the initiation of glomerulosclerosis

1 reference

12 December 2020

Monocyte chemoattractant protein-1 (MCP-1) in the kidney: does it more than simply attract monocytes?

1 reference

12 December 2020

Cytokine interactions promote synergistic fibronectin accumulation by mesangial cells

1 reference

12 December 2020

Targeting the MCP-1/CCR2 System in diabetic kidney disease

1 reference

12 December 2020

Added value of soluble tumor necrosis factor-α receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetes

1 reference

12 December 2020

Pentoxifylline suppression of tumor necrosis factor gene transcription

1 reference

12 December 2020

Tumor necrosis factor: function, release and clearance.

1 reference

12 December 2020

Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoattractant protein-1 expression in mesangial cells through downregulation of receptor for AGEs via peroxisome proliferator-ac

1 reference

12 December 2020

Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy

1 reference

12 December 2020

Effect of TNF-alpha inhibition on urinary albumin excretion in experimental diabetic rats

1 reference

12 December 2020

Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients

1 reference

12 December 2020

Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice

1 reference

12 December 2020

Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glom

1 reference

12 December 2020

Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation

1 reference

12 December 2020

Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria

1 reference

12 December 2020

Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db mice

1 reference

12 December 2020

Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells.

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

10.1007/S12020-014-0437-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273317%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference